1,931
Views
56
CrossRef citations to date
0
Altmetric
Original Articles

Prevalence of chronic obstructive pulmonary disease in rural women of Tamilnadu: implications for refining disease burden assessments attributable to household biomass combustion

, , , , , , , , & show all
Article: 7226 | Received 25 Apr 2011, Accepted 29 Sep 2011, Published online: 03 Nov 2011

References

  • The Global Burden of Diseases: World Health Organization. 2004. Available from: http://www.who.int/healthinfo/global_burden_disease/2004...update/en/. [cited 8 May 2011].
  • World Health Organization. Global strategy for diagnosis, management, and prevention of COPD. Geneva: World Health Organization. 2006. Available from: http://www.goldcopd.com/Guidelineitem. [cited 7 March 2007].
  • Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004; 23: 932–46.
  • C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009; 18: 213–21.
  • Jindal SK, Aggarwal AN, Gupta D. A review of population studies from India to estimate national burden of COPD and its association with smoking. Indian J Chest Dis Allied Sci. 2001; 43: 139–47.
  • Feenstra TL, Van Genugten ML, Hoogenveen RT, Wouters EF, Rutten-van Molken MP. The impact of ageing and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med. 2001; 164: 590–6.
  • Klaus FR, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al.. Global strategy for diagnosis, management, and prevention of COPD. Am J Respir Crit Care Med. 2007; 176: 532–55.
  • Yin P, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR, et al.. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet. 2007; 370: 751–7.
  • Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD, et al.. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. J Environ public Health. 2005; 4: 7.
  • Smith KR, Mehta S, Maeusezahl-Feuz M. Indoor air pollution from household solid fuel use. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Ezzati M, Lopez AD, Rodgers A, Murray CJLWorld Health Organization. Geneva, 2004; 1435–93.
  • Naeher LP, Brauer M, Lipsett M, et al.. Woodsmoke health effects: a review. Inhal Toxicol. 2007; 19: 67–106.
  • Balakrishnan K, Sankar S, Parikh J, et al.. Daily average exposures to respirable particulate matter from combustion of biomass fuels in rural households of southern India. Environ Health Perspect. 2002; 110: 1069–75.
  • Balakrishnan K, Sankar S, Padmavathi R, et al.. Exposures to respirable particulate matter associated with household fuel use in Andhra Pradesh, India. J Expo Anal Environ. 2004; 14: S14–S25.
  • He G, Ying B, Liu J, Gao S, Shen S, Balakrishnan K, et al.. Patterns of household concentrations of multiple indoor air pollutants in China. Env Sci Tech. 2005; 39: 991–8.
  • Ezzati M, Lopez AD, Rodgers A, Murray CJL. Comparative quantification of health risks: the Global and regional burden of disease attributable to selected major risk factors. ( Volumes 1 and 2). Geneva: World Health Organization. 2004.
  • Census of India. 2001. Available from: http://web.archive.org/web/20040616075334/ and http://www.censusindia.net/results/town. [cited 12 August 2006].
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.. Series “ATS/ERS task force: Standardisation of lung function testing” – Standardisation of spirometry. Eur Respir J. 2005; 26: 319–38.
  • Vijayan VK, Kuppurao KV, Venkatesan P, Sankaran K. Reference values and prediction equations for maximal expiratory flow rates in non-smoking normal subjects in Madras. Indian J Physiol Pharmacol. 1993; 37: 291–7.
  • Wise JB, Posner A, Walker GL. Verbal messages strengthen bench press efficacy. J Strength Cond Res. 2004; 18: 26–29.
  • Moggridge C, Barnes H, Dixon L, Catrin J. Effects of verbal encouragement on spirometry measurements in healthy adults. Health Soc Work. 2010; 2: 54–65.
  • Manríquez J, Díaz OP, Medoza LI, Borzone GTY, Lisboa CB. Spirometric reversibility in COPD patients: 200 or 400 mg salbutamol should be used?. Rev Chil Enferm Respir. 2006; 22: 168–75.
  • Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D, et al.. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci. 2006; 48: 23–9.
  • Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates. What is the true burden of disease?. Chest. 2003; 123: 1684–92.
  • Halbert RJ, Natoli JL, Gano A, et al.. Global burden of COPD: Systematic review and meta-analysis. Eur Respir J. 2006; 28: 523–32.
  • Thiruvengadam KV, Raghva TP, Bhardwaj KV. Survey of prevalence of chronic bronchitis in Madras city. Advances in chronic obstructive lung disease. Viswanath R, Jaggi OPAsthma and Bronchitis Foundation of India. Delhi, 1977; 59–69.
  • Ray D, Abel R, Selvaraj KG. A 5-year prospective epidemiological study of chronic obstructive pulmonary disease in rural south India. Indian J Med Res. 1995; 101: 238–44.
  • Jindal SK. A field study on follow up at 10 years of prevalence of chronic obstructive pulmonary disease & peak expiratory flow rate. Indian J Med Res. 1993; 98: 20–6.
  • Lacasse Y, Montori VM, Lanthier C, Maltis F. The validity of diagnosing chronic obstructive pulmonary disease from a large administrative database. Can Respir J. 2005; 12: 251–6.
  • Cricelli C, Mazzaglia G, Samani F, Marchi M, Sabatini A, Nardi R, et al.. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med. 2003; 25: 254–7.
  • Stang P, Lydick E, Silberman C, Kempel A, Keating ET. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest. 2000; 117: S354–9.
  • Chengappa C, Edwards R, Bajpai R, Naumoff Shields K, Smith KR. Impact of improved cookstoves on indoor air quality in the Bundelkhand region in India. Energy for Sustainable Development. 2007; 11: 33–44.
  • Liu S, Zhou Y, Wang X, Wang D, Lu J, Zheng J, et al.. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax. 2007; 62: 889–97.
  • Hu G, Zhou Y, Yao W, Li J, Li B, RanP. Risk of COPD from exposure to biomass smoke: a meta analysis. Chest. 2010; 138: 20–31.
  • Smith KR. National burden of disease in India from indoor air pollution. Proc Natl Acad Sci USA. 2000; 97: 13286–293.
  • Desai MA, Mehta S, Smith KR. Indoor smoke from solid fuels: assessing the environmental burden of disease at national and local levels. WHO Environmental Burden of Disease Series, No.4, Geneva: World Health Organization. 2004.
  • Tesfaigzi Y, McDonald JD, Reed MD, Singh SP, De Sanctis GT, Eynott PR, et al.. Low-level subchronic exposure to wood smoke exacerbates inflammatory responses in allergic rats. Toxicol Sci. 2005; 88: 505–13.
  • Lal K, Dutta KK, Vachhrajani KD, Gupta GS, Srivastava AK. Histomorphological changes in lung of rats following exposure to wood smoke. Indian J Exp Biol. 1993; 31: 761–4.
  • Balakrishnan K, Nigel BWHO Air Quality Guidelines Global Update. Indoor air pollution quality issues associated with domestic fuel combustion in developing countries. Geneva: World Health Organisation. 2006, pp. 189–207.
  • Arnolda BF, Khush RS, Ramaswamy P, London A, Rajkumar P,Ramaprabha P, et al.Causal inference methods to study nonrandomized, preexisting development interventions. Proc Natl Acad Sci USA. 2010; 107: 22605–10. http://www.pnas.org/content/107/52/22605.